.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC11_Iloprost.Iloprost

Information

name:Iloprost
ATC code:B01AC11
route:intravenous
n-compartments2

Iloprost is a synthetic analogue of prostacyclin (PGI2), used as a vasodilator and inhibitor of platelet aggregation. It is primarily indicated for the treatment of pulmonary arterial hypertension (PAH), Raynaud's phenomenon, and critical limb ischemia. Iloprost is approved and in use today as an inhalation or intravenous therapy.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adults receiving intravenous iloprost infusion.

References

  1. Galiè, N, et al., & Branzi, A (2003). Prostanoids for pulmonary arterial hypertension. American journal of respiratory medicine : drugs, devices, and other interventions 2(2) 123–137. DOI:10.1007/BF03256644 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14720012

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos